After 3 cancer diagnoses, Kentucky woman becomes first in state to participate in groundbreaking neutropenia clinical trial Norton Healthcare
Jennifer S. Buell: Calling for Immediate Action to Expand Access to Promising Cancer Treatments Oncodaily
Paulo de Castro: Investigating Catheter-Related Thrombosis in Cancer Patients at ESMO 2026 Oncodaily
Keratin 18 linked to aggressive head and neck cancer and lymph node spread Bioengineer.org
In a new study published in Cancer Cell, researchers at VIB-KU Leuven reduced the spread of glioblastoma by interrupting specific interactions between the brain's immune cells and tumor cells. The discovery points to a possible new therapeutic strategy, in which blocking communication between immune and cancer cells…
Tango reports 82% tumor response rate in trial of combo therapy for advanced pancreatic cancer The Boston Globe
Toufic Kachaamy: What Does It Take to Turn Innovation Into Better Cancer Care? Oncodaily
At ESMO, Oncologists Review Rasonque Subgroup Activity, Frontline Data on KRAS G12D Inhibitors GenomeWeb
Research led by professor of pathology Mikhail Nikiforov, Ph.D., has identified a key mechanism that helps cancer cells spread to the brain, which may lead to a new target for future therapies. The findings were published in the journal Cell Reports in the article "SERINC2-mediated phosphatidylserine remodeling…
Опухоль оставляет следы в жидкости: новый анализ помог уточнить диагноз у части пациентов Правда.Ру
AstraZeneca рассматривает разработку вакцин против рака Финам
Can Invikafusp Alfa Offer New Hope for Patients With Resistant Cancers? - The National Cancer Institute Oncodaily
Seton Hall professor receives $100,000 cancer research grant The Setonian
